Merck & Co., Inc. (MRK) announced Tuesday that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to ...

The FDA’s Fast Track designation is designed to facilitate the development and expedite the review of drugs intended to treat serious conditions that demonstrate the potential to fill an unmet medical ...

Since the start of the year, Ipsen has bolstered its oncology pipeline with two ADC alliances – with Foreseen Bio and Sutro ...

Nov. 26, 2024 — Scientists have shed new light on how certain biological processes determine the development of neural cells. Their findings on a molecular 'bridge' complex demonstrate a new ...

At the conference, AstraZeneca and Daiichi Sankyo will present their case for Dato-DXd in NSCLC, while BioNTech and Merus ...

Adcentrx Therapeutics ("Adcentrx"), a clinical-stage biotechnology company advancing innovative protein conjugates for cancer and other life-threatening diseases, today announced the dosing of the ...

An India-based research team has boosted the power conversion efficiency and stability of indoor dye-sensitized solar cells ...

March 26, 2024, was a weird day for me because it was the only one in my life where I was actively trying to get bitten by ...

Gilead and Tubulis Enter Into Exclusive Option and License Agreement to Develop ADC Candidate for Select Solid Tumor Target ...

A precancerous cell is a cell with certain abnormalities that makes it more likely to become cancerous. These abnormalities don't mean that it will become cancer—in fact, most don't—but the diagnosis ...

Roth Mkm started coverage on shares of GT Biopharma (NASDAQ:GTBP – Free Report) in a report published on Monday morning, MarketBeat.com reports. The firm issued a buy rating and a $11.00 price target ...

"The blood-brain barrier is an essential defense mechanism, but it also presents a significant challenge for delivering drugs ...